AMPE Related FDA

Jul 9, 2012 06:45 AM Ampio Pharma (AMPE) Reports Significant Data from Optina Trial on DME

Jul 2, 2012 09:06 AM Ampio (AMPE) Will Proceed with Zertane Development Following Positive Pre-IND Meetings

Jun 11, 2012 07:00 AM Ampio Pharma (AMPE) Says CRO Completes Analysis of Optina Trial for DME; Reports Significant Interaction

May 11, 2012 07:01 AM Ampio (AMPE) Completes Pre-IND Meeting with FDA's CBER for Ampion

Apr 30, 2012 07:08 AM Ampio Pharma (AMPE) Reports Statistically Significant Data from Ampion in the Knee Analysis

Apr 27, 2012 07:10 AM Ampio (AMPE) Gets U.S. Patent for DME Drug Optina

Apr 9, 2012 07:07 AM Ampio (AMPE) Submits Pre-IND Package on Zertane to FDA

Apr 2, 2012 07:08 AM Ampio (AMPE) Reaches Agreement for Zertane CTD Preparation in Australia

Mar 22, 2012 07:04 AM Ampio Pharma (AMPE) Enters Exclusive Zertane License Agreement with FMBFarma

Mar 20, 2012 07:18 AM Ampio (AMPE) Gets Additional Patent for Ampion

Mar 19, 2012 07:06 AM Ampio Pharma (AMPE) Issues Prelim. Update on Optina Clinical Trial; Concluded Study Ahead of Schedule, to Request Meeting with FDA

Jan 31, 2012 07:10 AM Ampio Pharmaceuticals (AMPE) Reports Significant Improvements in Pain Relief for Ampion in Knee Osteoarthritis Trial

Jan 3, 2012 07:03 AM Ampio (AMPE) Expands AIK Enrollment in Australia

Oct 18, 2011 07:23 AM Ampio Pharma (AMPE) Reports Low-Dose Intranasal Danazol has Impact on Allergic Rhinitis

Sep 26, 2011 08:20 AM Ampio Pharma (AMPE) Reports Positive Data from Zertane Phase III in Patients with PE